You are here

Article info

Article menu
Basic tumor immunology
Original research
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation

Authors

  • Biying Zhang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Jiao Li Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Qingling Hua Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Haihong Wang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Guojie Xu Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Jiayuan Chen Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Ying Zhu Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Ruiqi Li Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Qing Liang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Lanqing Wang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Min Jin Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Jing Tang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Zhenyu Lin Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Lei Zhao Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Dejun Zhang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Dandan Yu Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Jinghua Ren Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  • Tao Zhang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Tao Zhang; taozhangxh{at}hust.edu.cn; Dr Jinghua Ren; jhrenmed{at}hust.edu.cn; Dandan Yu; yudandan{at}hust.edu.cn
View Full Text

Citation

Zhang B, Li J, Hua Q, et al
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
Journal for ImmunoTherapy of Cancer 2023;11:e005592. doi: 10.1136/jitc-2022-005592

Publication history

  • Accepted December 15, 2022
  • First published January 3, 2023.
Online issue publication 
January 03, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.